CORRECTION article

Front. Oncol., 10 May 2022

Sec. Molecular and Cellular Oncology

Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.905360

Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression

  • 1. Department of Dermatology, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

  • 2. Department of Clinical Laboratory Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China

Following the publication of the original article, the authors found a few unintentional errors in Figures 2D, G. The authors clarify that corrections were made in Figures 2D, G panels, as follows: (1) an image overlap was corrected in Figure 2D, more specifically in the representative images of invasive A375 cells between LNMAT1 shRNA (Figure 2D) when compared to LNMAT1 siRNA + siRNA NC (Figure 4G). The representative image of invasive A375 cells of LNMAT1 siRNA group + siRNA NC shown in Figure 4G is accurate, and the representative image of invasive A375 cells of LNMAT1 shRNA shown in Figure 2D is now corrected; (2) In Figure 2G, the images of Day 0 and Day 10 were corrected, since there were overlapping issues between different images. The corrected figures appear below.

Figure 2

Figure 4

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

LNMAT1, EZH2, CADM1, invasion-metastasis cascade, malignant melanoma

Citation

Mou K, Zhang X, Mu X, Ge R, Han D, Zhou Y and Wang L-J (2022) Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression. Front. Oncol. 12:905360. doi: 10.3389/fonc.2022.905360

Received

28 March 2022

Accepted

11 April 2022

Published

10 May 2022

Volume

12 - 2022

Edited and reviewed by

Patricia P. Reis, São Paulo State University, Brazil

Updates

Copyright

*Correspondence: Li-Juan Wang,

This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics